Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

A new compound effectively inhibits human 5α-reductase 1.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Some supplements may help with hair loss, but there's not enough strong evidence to recommend them without doctor advice.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Four-amino acid part makes enzyme sensitive to finasteride.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.